marketcap
Facebook
X
TelegramAnnual report 2024
added 11-08-2025
Novartis AG DIO Ratio 2011-2025 | NVS
Annual DIO Ratio Novartis AG
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 130 | 131 | 128 | 135 | 131 | 114 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 135 | 114 | 128 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
34.5 | $ 4.37 | -1.58 % | $ 28.1 M |  China |
 |
Axon Enterprise
AXON
|
116 | $ 584.64 | -2.97 % | $ 44.3 B |  USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
130 | $ 1.93 | -3.02 % | $ 22.1 M |  Israel |
 |
Sorrento Therapeutics
SRNE
|
67.2 | $ 0.27 | -29.58 % | $ 126 M | USA |
 |
Orchard Therapeutics plc
ORTX
|
146 | $ 4.93 | 1.02 % | $ 90.8 M |  Britain |
 |
Midatech Pharma plc
MTP
|
40.6 | $ 0.29 | -18.52 % | $ 27.3 M | Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
281 | $ 6.2 | - | $ 154 M | USA |
 |
Aeterna Zentaris
AEZS
|
55.6 | $ 5.72 | 5.93 % | $ 314 M |  Canada |
 |
Kadmon Holdings, Inc.
KDMN
|
18.6 | $ 9.5 | - | $ 1.7 B | USA |
 |
BioDelivery Sciences International
BDSI
|
321 | $ 2.58 | -4.8 % | $ 255 M | USA |
 |
Albireo Pharma
ALBO
|
26.1 | $ 44.15 | -0.23 % | $ 916 M | USA |
 |
ImmuCell Corporation
ICCC
|
147 | $ 6.16 | 0.98 % | $ 50.3 M | USA |
 |
Caladrius Biosciences
CLBS
|
35.8 | $ 0.43 | -16.75 % | $ 25.8 M | USA |
 |
Jaguar Health
JAGX
|
1.82 K | $ 1.67 | -6.46 % | $ 492 K | USA |
 |
Eli Lilly and Company
LLY
|
290 | $ 967.93 | 4.71 % | $ 872 B | USA |